Showing results (241-250 of 275) with videos related to

Sort By:
Pageof 28
Chinese Medicine|February 15, 2014
Lignans from the bark of Eucommia ulmoides inhibited Ang II-stimulated extracellular matrix biosynthesis in mesangial cellsZhen-Yu Li, Xiao-Lan Deng, Wei-Hua Huang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|October 15, 2019
[Curative Efficacy of Rituximab for ITP Patients with Different Sensitivity to Hormone]Jun-Xiu Liu, Huan-Xin Zhang, De-Peng Li, et al.
International Journal of Biological Macromolecules|March 4, 2014
The D14 and R138 ion pair is involved in dimeric arginine kinase activity, structural stability and foldingHong-Li Geng, Mei-Ru Bian, Yang Liu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 17, 2018
[Risk Factors and Prognosis of Hepatic cGVHD after Allogeneic Hematopoietic Stem Cell Transplantation]Di Yu, Ya-Hui Han, Chen-Yuan Hu, et al.
Magnetic Resonance in Chemistry : MRC|February 28, 2012
Urinary metabonomic study using a CUMS rat model of depressionXiao-Jie Liu, Zhen-Yu Li, Zhong-Feng Li, et al.
International Journal of Clinical and Experimental Medicine|February 10, 2015
IL1RAP as a surface marker for leukemia stem cells is related to clinical phase of chronic myeloid leukemia patientsKai Zhao, Ling-Ling Yin, Dong-Mei Zhao, et al.
International Journal of Biological Macromolecules|May 22, 2018
Roles of germline JAK2 activation mutation JAK2 V625F in the pathology of myeloproliferative neoplasmsQing-Yun Wu, Meng-Meng Ma, Lin Fu, et al.
Archives of Biochemistry and Biophysics|September 11, 2012
Amino acid residue E543 in JAK2 C618R is a potential therapeutic target for myeloproliferative disorders caused by JAK2 C618R mutationQing-Yun Wu, Feng Li, Hua-Yan Guo, et al.
Pageof 28